CRAVIOTTO, Luisa
 Distribuzione geografica
Continente #
NA - Nord America 883
EU - Europa 849
AS - Asia 446
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.192
Nazione #
US - Stati Uniti d'America 871
CN - Cina 346
IE - Irlanda 202
SE - Svezia 183
FI - Finlandia 157
IT - Italia 141
DE - Germania 50
TR - Turchia 48
SG - Singapore 37
UA - Ucraina 26
GB - Regno Unito 21
BE - Belgio 16
CZ - Repubblica Ceca 16
CA - Canada 12
AT - Austria 11
FR - Francia 11
IN - India 8
CI - Costa d'Avorio 7
EU - Europa 4
ES - Italia 3
IR - Iran 3
RO - Romania 3
MA - Marocco 2
SM - San Marino 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CM - Camerun 1
HK - Hong Kong 1
JP - Giappone 1
KH - Cambogia 1
LU - Lussemburgo 1
MD - Moldavia 1
NL - Olanda 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 2.192
Città #
Dublin 202
Chandler 194
Ann Arbor 94
Ashburn 78
Beijing 73
Dearborn 62
Nanjing 51
Shanghai 49
Parma 47
Izmir 38
Jacksonville 35
Princeton 34
New York 32
Boardman 19
Kunming 18
Wilmington 18
Jinan 17
San Mateo 17
Brussels 16
Shenyang 16
Singapore 15
Brno 14
Helsinki 14
Woodbridge 14
Bremen 13
Nanchang 13
Los Angeles 11
Vienna 11
Dallas 10
Toronto 10
Changsha 9
Hebei 9
Jiaxing 9
Norwalk 9
Tianjin 9
Kocaeli 8
Milan 8
Pune 8
Abidjan 7
Hefei 7
San Antonio 7
Bologna 6
Mestre 6
Zhengzhou 6
Des Moines 5
Düsseldorf 4
Guangzhou 4
Haikou 4
Hangzhou 4
London 4
Redwood City 4
Rio Saliceto 4
Rome 4
Seattle 4
Cesena 3
Fremont 3
Fuzhou 3
Houston 3
Modena 3
Munich 3
Palermo 3
Pavia 3
Ardabil 2
Bergamo 2
Carpi 2
Casablanca 2
Catania 2
Chengdu 2
Chicago 2
Focsani 2
Frankfurt am Main 2
Grafing 2
Leawood 2
Manchester 2
Nanning 2
Ningbo 2
Piacenza 2
Rockville 2
Romainville 2
Santa Clara 2
Seville 2
Southend 2
Taiyuan 2
Turin 2
Washington 2
West Jordan 2
Amsterdam 1
Auburn Hills 1
Bandar Seri Begawan 1
Belgrade 1
Borås 1
Bucharest 1
Castelfranci 1
Chisinau 1
Chongqing 1
Esslingen am Neckar 1
Florence 1
Formigine 1
La Puebla De Arganzón 1
Lausanne 1
Totale 1.470
Nome #
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 112
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 101
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 99
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 99
A case of evolution of cutaneous mastocytosys into indolent systemic mastocytosis without evidence of c-kit mutation asp-816-val 93
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 91
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 90
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 88
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 76
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 76
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 75
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 73
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 73
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 66
Trascriptome Analysis of Bone Marrow CD14+ Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance 65
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 64
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 63
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. 62
A distintive nuclear morfology in three cases of acute myeloid leukaemia associated with loss HLA-DR expression and FTL3 internal tandem duplication 61
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 59
Relationship between bone imaging features and bone marrow cytokine and chemokine profiles in patients with monoclonal gammopathy 58
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 56
Role of 1q21 in multiple myeloma: From pathogenesis to possible therapeutic targets 52
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma 51
Relationship between presence of osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: role of chemokine (C-C motif) ligand 20 50
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation 50
Transcriptional and proteomic profiles of bone marrow CD14+ cells in multiple myeloma (MM) compared to smoldering MM and MGUS: overexpression of Interleukin (IL)-21 receptor and its involvement in MM-induced osteoclastogenesis 47
Haploidentical hematopoietic stem cell transplantation in adults using the αβTCR/CD19-based depletion of G-CSF-mobilized peripheral blood progenitor cells 47
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors 45
Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma preliminary results of a multicenter study by the italian non-hodgkin's lymphoma cooperative study group (NHLCSG) 40
MOLECULAR MONITORING OF PCM1-JAK2 FUSION TRANSCRIPT IN A CASE OF ATYPICAL CHRONIC MYELOID LEUKEMIA WITH T(8;9)(P22;24) 37
The impact of CD56 expression in smoldering myeloma patients on early progression 36
The role of proteasome inhibitors in multiple myeloma bone disease and bone metastasis: Effects on osteoblasts and osteocytes 31
[Clinical applications of autologous bone marrow transplants. Technical aspects and purification] 29
Vacuolated and signet-ring plasma cells in Waldenström macroglobulinemia 16
CD38 expression by plasma cells in extramedullary multiple myeloma 10
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 9
Totale 2.250
Categoria #
all - tutte 8.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 70 12 8 23 57 44 14 34 28 16 12
2020/2021168 1 13 8 7 24 5 13 12 42 13 24 6
2021/2022177 5 8 2 15 10 4 19 16 9 17 11 61
2022/2023753 76 92 55 49 49 83 16 55 234 9 25 10
2023/2024350 8 30 9 10 30 87 34 29 11 22 18 62
2024/202526 17 9 0 0 0 0 0 0 0 0 0 0
Totale 2.250